- Tilray launched products through licensed retailers in Canada on May 28, 2026.
- Tilray, a company based in Canada, has begun exporting medical-grade cannabis products to markets in Europe.
- Tilray secured a partnership to distribute medical cannabis products in Italy, while Trump's administration considers reclassifying cannabis.
Trump's administration is looking to reclassify marijuana, which could reshape the pot industry, involving Aurora Cannabis and TD Cowen.
2 reports, 2 independent
Updated Jun 29
Gone quiet
- Reports
- 2
- Developments
- 3
- Repetition
- 50%
New informationRepeats or wire copies
AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.
What happened
Trump's administration is looking to reclassify marijuana, which could reshape the pot industry, involving Aurora Cannabis and TD Cowen.
Who's involved
What this event is mainly aboutHow it developed
Newest first. Tap a step to see who reported it.- Rate reduction affects market prices and sustainability for CanniMed.Sub-event
- An executive order has been pushed for the expeditious reclassification of Canopy Growth.Sub-event
Trump's administration is considering reclassifying marijuana, potentially reshaping the pot industry.1 source
Keep exploring
The entities involved
-
Department of Health & Human Services
government department in the state of Victoria, Australia
-
Donald Trump
American businessman and politician (born 1946), President of the United States (2017–2021; since 2025)
-
CanniMed
Canadian public licensed producer of medical cannabis
Coverage
Newest first; wire copies grouped- fox5dc.com
- ReutersExplainer-How US marijuana reclassification could help cannabis companies (Reuters) -U.S. President Donald Trump's administration is looking to reclassify marijuana as a less dangerous drug, a shift